The global pharmaceutical manufacturing market size is expected to reach USD 929.9 billion by 2030. The market is expected to grow at a CAGR of 7.63% from 2023 to 2030. The pharmaceutical industry has undergone significant transformations as a result of technological advancements, cost-effective methods, and increased investments. These factors have had a positive impact on the growth of the market. The implementation of robotic technology and Artificial Intelligence (AI) has played a crucial role in reducing manufacturing floor downtime and minimizing product waste. By incorporating these technologies, efficiency, and productivity in pharmaceutical manufacturing processes have been greatly improved. ![Global Pharmaceutical Manufacturing Market]( "Global Pharmaceutical Manufacturing Market")
In addition, traditional open-transfer manufacturing methods have been replaced by the adoption of single-use disposable solutions, leading to streamlined operations and reduced risks of contamination. Moreover, there has been a notable shift toward integrated, smart, and data-rich paperless operations within the industry. This transition has resulted in error-free and precise production processes, ensuring the production of high-quality pharmaceutical products. These ongoing advancements in the market have significantly contributed to the progress of drug manufacturing. The development of personalized medicine has brought about a revolution in the healthcare sector, offering new opportunities to target various health conditions and paving the way for patient-centric models.
Consequently, there has been a shift from large-scale production to smaller batches to cater to the development of complex medicines and personalized treatments tailored to individual patients. This transformative shift has prompted manufacturers to restructure their supply chains in alignment with the patient-centric healthcare system. All such factors propel pharmaceutical manufacturing market growth over the forecast period. Furthermore, leading companies in the pharmaceutical industry have taken strategic initiatives to enhance their market presence and gain a competitive advantage. These key players actively engage in various activities, such as product development, collaboration & partnership models, agreements, business expansion, and merger & acquisition strategies.
These initiatives are also aimed at strengthening their product portfolios and meeting the growing demand for pharmaceutical products. For instance, in April 2022, Ferring Pharmaceuticals inaugurated an integrated manufacturing and research and development (R&D) facility in Hyderabad, India. This facility underscores Ferring's commitment to expanding its operations and capabilities. The R&D division of the facility focuses on areas, such as packaging development, formulation development, and analytical development. Ferring Pharmaceuticals aims to enhance its product offerings and meet the evolving needs of the market by investing in these areas.
In addition, traditional open-transfer manufacturing methods have been replaced by the adoption of single-use disposable solutions, leading to streamlined operations and reduced risks of contamination. Moreover, there has been a notable shift toward integrated, smart, and data-rich paperless operations within the industry. This transition has resulted in error-free and precise production processes, ensuring the production of high-quality pharmaceutical products. These ongoing advancements in the market have significantly contributed to the progress of drug manufacturing. The development of personalized medicine has brought about a revolution in the healthcare sector, offering new opportunities to target various health conditions and paving the way for patient-centric models.
Consequently, there has been a shift from large-scale production to smaller batches to cater to the development of complex medicines and personalized treatments tailored to individual patients. This transformative shift has prompted manufacturers to restructure their supply chains in alignment with the patient-centric healthcare system. All such factors propel pharmaceutical manufacturing market growth over the forecast period. Furthermore, leading companies in the pharmaceutical industry have taken strategic initiatives to enhance their market presence and gain a competitive advantage. These key players actively engage in various activities, such as product development, collaboration & partnership models, agreements, business expansion, and merger & acquisition strategies.
These initiatives are also aimed at strengthening their product portfolios and meeting the growing demand for pharmaceutical products. For instance, in April 2022, Ferring Pharmaceuticals inaugurated an integrated manufacturing and research and development (R&D) facility in Hyderabad, India. This facility underscores Ferring's commitment to expanding its operations and capabilities. The R&D division of the facility focuses on areas, such as packaging development, formulation development, and analytical development. Ferring Pharmaceuticals aims to enhance its product offerings and meet the evolving needs of the market by investing in these areas.
Pharmaceutical Manufacturing Market Report Highlights
- In 2022, the conventional drugs (small molecules) segment accounted for the highest revenue share of over 54.9%. This is attributed to the easy availability of small molecules products, with high market penetration
- The outsourcing segment dominated the market in 2022 with a revenue share of over 53%. Several benefits associated with outsourcing operations are expected to drive the segment growth at a lucrative pace over the coming years
- In terms of revenue, the tablets segment dominated the market with a share of over 26.08 % in 2022. This is due to the wide availability of tablet-based products and types, such as film and enteric-coated, effervescent, and orally disintegrating tablets
- The oral segment led the global market with a share of more than 58% in 2022. Oral dosage forms are affordable, easy to manufacture, and patient-friendly
- The prescription medicines segment accounted for the maximum revenue share of 83.76% in 2022 and will expand further at a steady CAGR over the forecast period due to the growing prescription drug expenditures across the globe
- North America dominated the market and accounted for a significant revenue share in 2022 due to a large number of strategic pharma partnerships, especially among the well-established and early-stage companies, in this region
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Molecule Type
1.2.2. Drug Development Type
1.2.3. Formulation
1.2.4. Routes of Administration
1.2.5. Therapy Area
1.2.6. Prescription
1.2.7. Age Group
1.2.8. Sales Channel
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased database
1.6.2. The internal database
1.6.3. Secondary sources
1.6.4. Primary research
1.6.5. Details of primary research
1.7. Information or Data Analysis
1.7.1. Data analysis models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1.1. Commodity flow analysis (Model 1)
1.9.1.2. Approach 1: Commodity flow approach
1.9.1.3. Volume price analysis (Model 2)
1.9.1.4. Approach 2: Volume price analysis
1.10. List of Secondary Sources
1.11. List of Primary Sources
1.12. Objectives
1.12.1. Objective 1
1.12.2. Objective 2
1.2. Segment Definitions
1.2.1. Molecule Type
1.2.2. Drug Development Type
1.2.3. Formulation
1.2.4. Routes of Administration
1.2.5. Therapy Area
1.2.6. Prescription
1.2.7. Age Group
1.2.8. Sales Channel
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased database
1.6.2. The internal database
1.6.3. Secondary sources
1.6.4. Primary research
1.6.5. Details of primary research
1.7. Information or Data Analysis
1.7.1. Data analysis models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1.1. Commodity flow analysis (Model 1)
1.9.1.2. Approach 1: Commodity flow approach
1.9.1.3. Volume price analysis (Model 2)
1.9.1.4. Approach 2: Volume price analysis
1.10. List of Secondary Sources
1.11. List of Primary Sources
1.12. Objectives
1.12.1. Objective 1
1.12.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Molecule Type outlook
2.2.2. Drug Development Type outlook
2.2.3. Formulation outlook
2.2.4. Route of Administration outlook
2.2.5. Therapy Area outlook
2.2.6. Prescription outlook
2.2.7. Age Group outlook
2.2.8. Sales Channel outlook
2.2.9. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Molecule Type outlook
2.2.2. Drug Development Type outlook
2.2.3. Formulation outlook
2.2.4. Route of Administration outlook
2.2.5. Therapy Area outlook
2.2.6. Prescription outlook
2.2.7. Age Group outlook
2.2.8. Sales Channel outlook
2.2.9. Regional outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Rise in pharmaceutical R&D spending
3.3.1.2. Rise in focus toward healthcare needs in emerging nations
3.3.1.3. Technological advancements
3.3.1.4. Increase in geriatric population and incidence of chronic disorders
3.3.2. Market restraint analysis
3.3.2.1. Patent expiration of most profitable drugs
3.3.2.2. Pricing pressures on bio/pharmaceutical companies
3.4. Pharmaceutical manufacturing Market Analysis Tools
3.4.1. Industry Analysis - Porter's
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Rise in pharmaceutical R&D spending
3.3.1.2. Rise in focus toward healthcare needs in emerging nations
3.3.1.3. Technological advancements
3.3.1.4. Increase in geriatric population and incidence of chronic disorders
3.3.2. Market restraint analysis
3.3.2.1. Patent expiration of most profitable drugs
3.3.2.2. Pricing pressures on bio/pharmaceutical companies
3.4. Pharmaceutical manufacturing Market Analysis Tools
3.4.1. Industry Analysis - Porter's
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Pharmaceutical Manufacturing: Molecule Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Biologics & Biosimilars (Large Molecules)
4.1.2. Conventional Drugs (Small Molecules)
4.2. Molecule Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Pharmaceutical Manufacturing Market by Molecule Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Biologics & Biosimilars (Large Molecules)
4.5.1.1. Biologics & Biosimilars (Large Molecules) market estimates and forecast 2018 to 2030 (USD Billion)
4.5.1.2. Monoclonal Antibodies
4.5.1.2.1. Monoclonal Antibodies market estimates and forecast 2018 to 2030 (USD Billion)
4.5.1.3. Vaccines
4.5.1.3.1. Vaccines market estimates and forecast 2018 to 2030 (USD Billion)
4.5.1.4. Cell & Gene Therapy
4.5.1.4.1. Cell & Gene Therapy market estimates and forecast 2018 to 2030 (USD Billion)
4.5.1.5. Others
4.5.1.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
4.5.2. Conventional Drugs (Small Molecules)
4.5.2.1. Conventional Drugs (Small Molecules) market estimates and forecast 2018 to 2030 (USD Billion)
4.1.1. Biologics & Biosimilars (Large Molecules)
4.1.2. Conventional Drugs (Small Molecules)
4.2. Molecule Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Pharmaceutical Manufacturing Market by Molecule Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Biologics & Biosimilars (Large Molecules)
4.5.1.1. Biologics & Biosimilars (Large Molecules) market estimates and forecast 2018 to 2030 (USD Billion)
4.5.1.2. Monoclonal Antibodies
4.5.1.2.1. Monoclonal Antibodies market estimates and forecast 2018 to 2030 (USD Billion)
4.5.1.3. Vaccines
4.5.1.3.1. Vaccines market estimates and forecast 2018 to 2030 (USD Billion)
4.5.1.4. Cell & Gene Therapy
4.5.1.4.1. Cell & Gene Therapy market estimates and forecast 2018 to 2030 (USD Billion)
4.5.1.5. Others
4.5.1.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
4.5.2. Conventional Drugs (Small Molecules)
4.5.2.1. Conventional Drugs (Small Molecules) market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 5. Pharmaceutical Manufacturing: Drug Development Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. In-house
5.1.2. Outsource
5.2. Drug Development Type Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Microneedle Drug Delivery Systems Market by Drug Development Type Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
5.5.1. In-house
5.5.1.1. In-house market estimates and forecast 2018 to 2030 (USD Billion)
5.5.2. Outsource
5.5.2.1. Outsource market estimates and forecast 2018 to 2030 (USD Billion)
5.1.1. In-house
5.1.2. Outsource
5.2. Drug Development Type Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Microneedle Drug Delivery Systems Market by Drug Development Type Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
5.5.1. In-house
5.5.1.1. In-house market estimates and forecast 2018 to 2030 (USD Billion)
5.5.2. Outsource
5.5.2.1. Outsource market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 6. Pharmaceutical Manufacturing: Formulation Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Tablets
6.1.2. Capsules
6.1.3. Injectable
6.1.4. Sprays
6.1.5. Suspensions
6.1.6. Powders
6.1.7. Others
6.2. Formulation Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Pharmaceutical Manufacturing Market by Formulation Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Tablets
6.5.1.1. Tablets market estimates and forecast 2018 to 2030 (USD Billion)
6.5.2. Capsules
6.5.2.1. Capsules market estimates and forecast 2018 to 2030 (USD Billion)
6.5.3. Injectable
6.5.3.1. Injectable market estimates and forecast 2018 to 2030 (USD Billion)
6.5.4. Sprays
6.5.4.1. Sprays market estimates and forecast 2018 to 2030 (USD Billion)
6.5.5. Suspensions
6.5.5.1. Suspensions market estimates and forecast 2018 to 2030 (USD Billion)
6.5.6. Powders
6.5.6.1. Powders market estimates and forecast 2018 to 2030 (USD Billion)
6.5.7. Others
6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
6.1.1. Tablets
6.1.2. Capsules
6.1.3. Injectable
6.1.4. Sprays
6.1.5. Suspensions
6.1.6. Powders
6.1.7. Others
6.2. Formulation Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Pharmaceutical Manufacturing Market by Formulation Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Tablets
6.5.1.1. Tablets market estimates and forecast 2018 to 2030 (USD Billion)
6.5.2. Capsules
6.5.2.1. Capsules market estimates and forecast 2018 to 2030 (USD Billion)
6.5.3. Injectable
6.5.3.1. Injectable market estimates and forecast 2018 to 2030 (USD Billion)
6.5.4. Sprays
6.5.4.1. Sprays market estimates and forecast 2018 to 2030 (USD Billion)
6.5.5. Suspensions
6.5.5.1. Suspensions market estimates and forecast 2018 to 2030 (USD Billion)
6.5.6. Powders
6.5.6.1. Powders market estimates and forecast 2018 to 2030 (USD Billion)
6.5.7. Others
6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 7. Pharmaceutical Manufacturing: Route of Administration Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Oral
7.1.2. Topical
7.1.3. Parenteral
7.1.4. Inhalations
7.1.5. Others
7.2. Route of Administration Market Share, 2022 & 2030
7.3. Segment Dashboard
7.4. Global Pharmaceutical Manufacturing Market by Route of Administration Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Oral
7.5.1.1. Oral market estimates and forecast 2018 to 2030 (USD Billion)
7.5.2. Topical
7.5.2.1. Topical market estimates and forecast 2018 to 2030 (USD Billion)
7.5.3. Parenteral
7.5.3.1. Parenteral market estimates and forecast 2018 to 2030 (USD Billion)
7.5.4. Inhalations
7.5.4.1. Inhalations market estimates and forecast 2018 to 2030 (USD Billion)
7.5.5. Others
7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
7.1.1. Oral
7.1.2. Topical
7.1.3. Parenteral
7.1.4. Inhalations
7.1.5. Others
7.2. Route of Administration Market Share, 2022 & 2030
7.3. Segment Dashboard
7.4. Global Pharmaceutical Manufacturing Market by Route of Administration Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Oral
7.5.1.1. Oral market estimates and forecast 2018 to 2030 (USD Billion)
7.5.2. Topical
7.5.2.1. Topical market estimates and forecast 2018 to 2030 (USD Billion)
7.5.3. Parenteral
7.5.3.1. Parenteral market estimates and forecast 2018 to 2030 (USD Billion)
7.5.4. Inhalations
7.5.4.1. Inhalations market estimates and forecast 2018 to 2030 (USD Billion)
7.5.5. Others
7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 8. Pharmaceutical Manufacturing: Therapy Area Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Cardiovascular diseases
8.1.2. Pain
8.1.3. Diabetes
8.1.4. Cancer
8.1.5. Respiratory diseases
8.1.6. Others
8.2. Therapy Area Market Share, 2022 & 2030
8.3. Segment Dashboard
8.4. Global Pharmaceutical Manufacturing Market by Therapy Area Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. Cardiovascular diseases
8.5.1.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Billion)
8.5.2. Pain
8.5.2.1. Pain market estimates and forecast 2018 to 2030 (USD Billion)
8.5.3. Diabetes
8.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Billion)
8.5.4. Cancer
8.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Billion)
8.5.5. Respiratory diseases
8.5.5.1. Respiratory diseases market estimates and forecast 2018 to 2030 (USD Billion)
8.5.6. Others
8.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
8.1.1. Cardiovascular diseases
8.1.2. Pain
8.1.3. Diabetes
8.1.4. Cancer
8.1.5. Respiratory diseases
8.1.6. Others
8.2. Therapy Area Market Share, 2022 & 2030
8.3. Segment Dashboard
8.4. Global Pharmaceutical Manufacturing Market by Therapy Area Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. Cardiovascular diseases
8.5.1.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Billion)
8.5.2. Pain
8.5.2.1. Pain market estimates and forecast 2018 to 2030 (USD Billion)
8.5.3. Diabetes
8.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Billion)
8.5.4. Cancer
8.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Billion)
8.5.5. Respiratory diseases
8.5.5.1. Respiratory diseases market estimates and forecast 2018 to 2030 (USD Billion)
8.5.6. Others
8.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 9. Pharmaceutical Manufacturing: Prescription Estimates & Trend Analysis
9.1. Definitions and Scope
9.1.1. Prescription Medicines
9.1.2. Over-the-counter (OTC) medicines
9.2. Prescription Market Share, 2022 & 2030
9.3. Segment Dashboard
9.4. Global Pharmaceutical Manufacturing Market by Prescription Outlook
9.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
9.5.1. Prescription Medicines
9.5.1.1. Prescription Medicines market estimates and forecast 2018 to 2030 (USD Billion)
9.5.2. Over-the-counter (OTC) medicines
9.5.2.1. Over-the-counter (OTC) medicines market estimates and forecast 2018 to 2030 (USD Billion)
9.1.1. Prescription Medicines
9.1.2. Over-the-counter (OTC) medicines
9.2. Prescription Market Share, 2022 & 2030
9.3. Segment Dashboard
9.4. Global Pharmaceutical Manufacturing Market by Prescription Outlook
9.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
9.5.1. Prescription Medicines
9.5.1.1. Prescription Medicines market estimates and forecast 2018 to 2030 (USD Billion)
9.5.2. Over-the-counter (OTC) medicines
9.5.2.1. Over-the-counter (OTC) medicines market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 10. Pharmaceutical Manufacturing: Age Group Estimates & Trend Analysis
10.1. Definitions and Scope
10.1.1. Children & Adolescents
10.1.2. Adults
10.1.3. Geriatric
10.2. Age Group Market Share, 2022 & 2030
10.3. Segment Dashboard
10.4. Global Pharmaceutical Manufacturing Market by Age Group Outlook
10.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
10.5.1. Children & Adolescents
10.5.1.1. Children & Adolescents market estimates and forecast 2018 to 2030 (USD Billion)
10.5.2. Adults
10.5.2.1. Adults market estimates and forecast 2018 to 2030 (USD Billion)
10.5.3. Geriatric
10.5.3.1. Geriatric market estimates and forecast 2018 to 2030 (USD Billion)
10.1.1. Children & Adolescents
10.1.2. Adults
10.1.3. Geriatric
10.2. Age Group Market Share, 2022 & 2030
10.3. Segment Dashboard
10.4. Global Pharmaceutical Manufacturing Market by Age Group Outlook
10.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
10.5.1. Children & Adolescents
10.5.1.1. Children & Adolescents market estimates and forecast 2018 to 2030 (USD Billion)
10.5.2. Adults
10.5.2.1. Adults market estimates and forecast 2018 to 2030 (USD Billion)
10.5.3. Geriatric
10.5.3.1. Geriatric market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 11. Pharmaceutical Manufacturing: Sales Channel Estimates & Trend Analysis
11.1. Definitions and Scope
11.1.1. Retail
11.1.2. Non-retail
11.2. Sales Channel Market Share, 2022 & 2030
11.3. Segment Dashboard
11.4. Global Pharmaceutical Manufacturing Market by Sales Channel Outlook
11.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
11.5.1. Retail
11.5.1.1. Retail market estimates and forecast 2018 to 2030 (USD Billion)
11.5.2. Non-retail
11.5.2.1. Non-retail market estimates and forecast 2018 to 2030 (USD Billion)
11.1.1. Retail
11.1.2. Non-retail
11.2. Sales Channel Market Share, 2022 & 2030
11.3. Segment Dashboard
11.4. Global Pharmaceutical Manufacturing Market by Sales Channel Outlook
11.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
11.5.1. Retail
11.5.1.1. Retail market estimates and forecast 2018 to 2030 (USD Billion)
11.5.2. Non-retail
11.5.2.1. Non-retail market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 12. Pharmaceutical Manufacturing Market: Regional Estimates & Trend Analysis
12.1. Regional market share analysis, 2022 & 2030
12.2. Regional Market Dashboard
12.3. Global Regional Market Snapshot
12.4. Regional Market Share and Leading Players, 2021
12.4.1. North America
12.4.2. Europe
12.4.3. Asia Pacific
12.4.4. Latin America
12.4.5. Middle East and Africa
12.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
12.5.1. North America
12.5.2. Europe
12.5.3. Asia Pacific
12.5.4. Latin America
12.5.5. Middle East and Africa
12.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
12.7. North America
12.7.1. SWOT Analysis
12.7.2. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.7.3. U.S.
12.7.3.1. Key Country Dynamics
12.7.3.2. Target Disease Prevalence
12.7.3.3. Competitive Scenario
12.7.3.4. Regulatory Framework
12.7.3.5. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.7.4. Canada
12.7.4.1. Key Country Dynamics
12.7.4.2. Target Disease Prevalence
12.7.4.3. Competitive Scenario
12.7.4.4. Regulatory Framework
12.7.4.5. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8. Europe
12.8.1. SWOT Analysis
12.8.2. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.3. UK
12.8.3.1. Key Country Dynamics
12.8.3.2. Target Disease Prevalence
12.8.3.3. Competitive Scenario
12.8.3.4. Regulatory Framework
12.8.3.5. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.4. Germany
12.8.4.1. Key Country Dynamics
12.8.4.2. Target Disease Prevalence
12.8.4.3. Competitive Scenario
12.8.4.4. Regulatory Framework
12.8.4.5. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.5. France
12.8.5.1. Key Country Dynamics
12.8.5.2. Target Disease Prevalence
12.8.5.3. Competitive Scenario
12.8.5.4. Regulatory Framework
12.8.5.5. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.6. Italy
12.8.6.1. Key Country Dynamics
12.8.6.2. Target Disease Prevalence
12.8.6.3. Competitive Scenario
12.8.6.4. Regulatory Framework
12.8.6.5. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.7. Spain
12.8.7.1. Key Country Dynamics
12.8.7.2. Target Disease Prevalence
12.8.7.3. Competitive Scenario
12.8.7.4. Regulatory Framework
12.8.7.5. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.8. Denmark
12.8.8.1. Key Country Dynamics
12.8.8.2. Target Disease Prevalence
12.8.8.3. Competitive Scenario
12.8.8.4. Regulatory Framework
12.8.8.5. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.9. Sweden
12.8.9.1. Key Country Dynamics
12.8.9.2. Target Disease Prevalence
12.8.9.3. Competitive Scenario
12.8.9.4. Regulatory Framework
12.8.9.5. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.10. Norway
12.8.10.1. Key Country Dynamics
12.8.10.2. Target Disease Prevalence
12.8.10.3. Competitive Scenario
12.8.10.4. Regulatory Framework
12.8.10.5. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9. Asia Pacific
12.9.1. SWOT Analysis
12.9.2. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.3. China
12.9.3.1. Key Country Dynamics
12.9.3.2. Target Disease Prevalence
12.9.3.3. Competitive Scenario
12.9.3.4. Regulatory Framework
12.9.3.5. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.4. Japan
12.9.4.1. Key Country Dynamics
12.9.4.2. Target Disease Prevalence
12.9.4.3. Competitive Scenario
12.9.4.4. Regulatory Framework
12.9.4.5. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
12.9.5. India
12.9.5.1. Key Country Dynamics
12.9.5.2. Target Disease Prevalence
12.9.5.3. Competitive Scenario
12.9.5.4. Regulatory Framework
12.9.5.5. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.6. Australia
12.9.6.1. Key Country Dynamics
12.9.6.2. Target Disease Prevalence
12.9.6.3. Competitive Scenario
12.9.6.4. Regulatory Framework
12.9.6.5. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.7. Thailand
12.9.7.1. Key Country Dynamics
12.9.7.2. Target Disease Prevalence
12.9.7.3. Competitive Scenario
12.9.7.4. Regulatory Framework
12.9.7.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.8. South Korea
12.9.8.1. Key Country Dynamics
12.9.8.2. Target Disease Prevalence
12.9.8.3. Competitive Scenario
12.9.8.4. Regulatory Framework
12.9.8.5. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.10. Latin America
12.10.1. SWOT Analysis
12.10.2. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.10.3. Brazil
12.10.3.1. Key Country Dynamics
12.10.3.2. Target Disease Prevalence
12.10.3.3. Competitive Scenario
12.10.3.4. Regulatory Framework
12.10.3.5. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.10.4. Mexico
12.10.4.1. Key Country Dynamics
12.10.4.2. Target Disease Prevalence
12.10.4.3. Competitive Scenario
12.10.4.4. Regulatory Framework
12.10.4.5. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.10.5. Argentina
12.10.5.1. Key Country Dynamics
12.10.5.2. Target Disease Prevalence
12.10.5.3. Competitive Scenario
12.10.5.4. Regulatory Framework
12.10.5.5. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11. MEA
12.11.1. SWOT Analysis
12.11.2. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11.3. Saudi Arabia
12.11.3.1. Key Country Dynamics
12.11.3.2. Target Disease Prevalence
12.11.3.3. Competitive Scenario
12.11.3.4. Regulatory Framework
12.11.3.5. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11.4. South Africa
12.11.4.1. Key Country Dynamics
12.11.4.2. Target Disease Prevalence
12.11.4.3. Competitive Scenario
12.11.4.4. Regulatory Framework
12.11.4.5. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11.5. UAE
12.11.5.1. Key Country Dynamics
12.11.5.2. Target Disease Prevalence
12.11.5.3. Competitive Scenario
12.11.5.4. Regulatory Framework
12.11.5.5. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11.6. Kuwait
12.11.6.1. Key Country Dynamics
12.11.6.2. Target Disease Prevalence
12.11.6.3. Competitive Scenario
12.11.6.4. Regulatory Framework
12.11.6.5. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.2. Regional Market Dashboard
12.3. Global Regional Market Snapshot
12.4. Regional Market Share and Leading Players, 2021
12.4.1. North America
12.4.2. Europe
12.4.3. Asia Pacific
12.4.4. Latin America
12.4.5. Middle East and Africa
12.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
12.5.1. North America
12.5.2. Europe
12.5.3. Asia Pacific
12.5.4. Latin America
12.5.5. Middle East and Africa
12.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
12.7. North America
12.7.1. SWOT Analysis
12.7.2. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.7.3. U.S.
12.7.3.1. Key Country Dynamics
12.7.3.2. Target Disease Prevalence
12.7.3.3. Competitive Scenario
12.7.3.4. Regulatory Framework
12.7.3.5. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.7.4. Canada
12.7.4.1. Key Country Dynamics
12.7.4.2. Target Disease Prevalence
12.7.4.3. Competitive Scenario
12.7.4.4. Regulatory Framework
12.7.4.5. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8. Europe
12.8.1. SWOT Analysis
12.8.2. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.3. UK
12.8.3.1. Key Country Dynamics
12.8.3.2. Target Disease Prevalence
12.8.3.3. Competitive Scenario
12.8.3.4. Regulatory Framework
12.8.3.5. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.4. Germany
12.8.4.1. Key Country Dynamics
12.8.4.2. Target Disease Prevalence
12.8.4.3. Competitive Scenario
12.8.4.4. Regulatory Framework
12.8.4.5. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.5. France
12.8.5.1. Key Country Dynamics
12.8.5.2. Target Disease Prevalence
12.8.5.3. Competitive Scenario
12.8.5.4. Regulatory Framework
12.8.5.5. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.6. Italy
12.8.6.1. Key Country Dynamics
12.8.6.2. Target Disease Prevalence
12.8.6.3. Competitive Scenario
12.8.6.4. Regulatory Framework
12.8.6.5. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.7. Spain
12.8.7.1. Key Country Dynamics
12.8.7.2. Target Disease Prevalence
12.8.7.3. Competitive Scenario
12.8.7.4. Regulatory Framework
12.8.7.5. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.8. Denmark
12.8.8.1. Key Country Dynamics
12.8.8.2. Target Disease Prevalence
12.8.8.3. Competitive Scenario
12.8.8.4. Regulatory Framework
12.8.8.5. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.9. Sweden
12.8.9.1. Key Country Dynamics
12.8.9.2. Target Disease Prevalence
12.8.9.3. Competitive Scenario
12.8.9.4. Regulatory Framework
12.8.9.5. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.8.10. Norway
12.8.10.1. Key Country Dynamics
12.8.10.2. Target Disease Prevalence
12.8.10.3. Competitive Scenario
12.8.10.4. Regulatory Framework
12.8.10.5. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9. Asia Pacific
12.9.1. SWOT Analysis
12.9.2. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.3. China
12.9.3.1. Key Country Dynamics
12.9.3.2. Target Disease Prevalence
12.9.3.3. Competitive Scenario
12.9.3.4. Regulatory Framework
12.9.3.5. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.4. Japan
12.9.4.1. Key Country Dynamics
12.9.4.2. Target Disease Prevalence
12.9.4.3. Competitive Scenario
12.9.4.4. Regulatory Framework
12.9.4.5. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
12.9.5. India
12.9.5.1. Key Country Dynamics
12.9.5.2. Target Disease Prevalence
12.9.5.3. Competitive Scenario
12.9.5.4. Regulatory Framework
12.9.5.5. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.6. Australia
12.9.6.1. Key Country Dynamics
12.9.6.2. Target Disease Prevalence
12.9.6.3. Competitive Scenario
12.9.6.4. Regulatory Framework
12.9.6.5. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.7. Thailand
12.9.7.1. Key Country Dynamics
12.9.7.2. Target Disease Prevalence
12.9.7.3. Competitive Scenario
12.9.7.4. Regulatory Framework
12.9.7.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.9.8. South Korea
12.9.8.1. Key Country Dynamics
12.9.8.2. Target Disease Prevalence
12.9.8.3. Competitive Scenario
12.9.8.4. Regulatory Framework
12.9.8.5. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.10. Latin America
12.10.1. SWOT Analysis
12.10.2. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.10.3. Brazil
12.10.3.1. Key Country Dynamics
12.10.3.2. Target Disease Prevalence
12.10.3.3. Competitive Scenario
12.10.3.4. Regulatory Framework
12.10.3.5. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.10.4. Mexico
12.10.4.1. Key Country Dynamics
12.10.4.2. Target Disease Prevalence
12.10.4.3. Competitive Scenario
12.10.4.4. Regulatory Framework
12.10.4.5. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.10.5. Argentina
12.10.5.1. Key Country Dynamics
12.10.5.2. Target Disease Prevalence
12.10.5.3. Competitive Scenario
12.10.5.4. Regulatory Framework
12.10.5.5. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11. MEA
12.11.1. SWOT Analysis
12.11.2. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11.3. Saudi Arabia
12.11.3.1. Key Country Dynamics
12.11.3.2. Target Disease Prevalence
12.11.3.3. Competitive Scenario
12.11.3.4. Regulatory Framework
12.11.3.5. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11.4. South Africa
12.11.4.1. Key Country Dynamics
12.11.4.2. Target Disease Prevalence
12.11.4.3. Competitive Scenario
12.11.4.4. Regulatory Framework
12.11.4.5. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11.5. UAE
12.11.5.1. Key Country Dynamics
12.11.5.2. Target Disease Prevalence
12.11.5.3. Competitive Scenario
12.11.5.4. Regulatory Framework
12.11.5.5. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
12.11.6. Kuwait
12.11.6.1. Key Country Dynamics
12.11.6.2. Target Disease Prevalence
12.11.6.3. Competitive Scenario
12.11.6.4. Regulatory Framework
12.11.6.5. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
Chapter 13. Competitive Landscape
13.1. Recent Developments & Impact Analysis, By Key Market Participants
13.2. Company/Competition Categorization
13.2.1. Innovators
13.3. Vendor Landscape
13.3.1. List of key distributors and channel partners
13.3.2. Key customers
13.3.3. Key company market share analysis, 2022
13.3.4. F. Hoffmann-La Roche Ltd.
13.3.4.1. Company overview
13.3.4.2. Financial performance
13.3.4.3. Product benchmarking
13.3.4.4. Strategic initiatives
13.3.5. Novartis AG
13.3.5.1. Company overview
13.3.5.2. Financial performance
13.3.5.3. Product benchmarking
13.3.5.4. Strategic initiatives
13.3.6. GlaxoSmithKline plc
13.3.6.1. Company overview
13.3.6.2. Financial performance
13.3.6.3. Product benchmarking
13.3.6.4. Strategic initiatives
13.3.7. Pfizer, Inc.
13.3.7.1. Company overview
13.3.7.2. Financial performance
13.3.7.3. Product benchmarking
13.3.7.4. Strategic initiatives
13.3.8. Merck & Co., Inc.
13.3.8.1. Company overview
13.3.8.2. Financial performance
13.3.8.3. Product benchmarking
13.3.8.4. Strategic initiatives
13.3.9. AstraZeneca
13.3.9.1. Company overview
13.3.9.2. Financial performance
13.3.9.3. Product benchmarking
13.3.9.4. Strategic initiatives
13.3.10. Johnson & Johnson Services, Inc.
13.3.10.1. Company overview
13.3.10.2. Financial performance
13.3.10.3. Product benchmarking
13.3.10.4. Strategic initiatives
13.3.11. Sanofi SA
13.3.11.1. Company overview
13.3.11.2. Financial performance
13.3.11.3. Product benchmarking
13.3.11.4. Strategic initiatives
13.3.12. Eli Lilly and Company
13.3.12.1. Company overview
13.3.12.2. Financial performance
13.3.12.3. Product benchmarking
13.3.12.4. Strategic initiatives
13.3.13. AbbVie, Inc.
13.3.13.1. Company overview
13.3.13.2. Financial performance
13.3.13.3. Product benchmarking
13.3.13.4. Strategic initiatives
13.3.14. Thermo Fisher Scientific, Inc.
13.3.14.1. Company overview
13.3.14.2. Financial performance
13.3.14.3. Product benchmarking
13.3.14.4. Strategic initiatives
13.3.15. Wuxi Apptec
13.3.15.1. Company overview
13.3.15.2. Financial performance
13.3.15.3. Product benchmarking
13.3.15.4. Strategic initiatives
13.3.16. Samsung Biologics
13.3.16.1. Company overview
13.3.16.2. Financial performance
13.3.16.3. Product benchmarking
13.3.16.4. Strategic initiatives
13.3.17. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
13.3.17.1. Company overview
13.3.17.2. Financial performance
13.3.17.3. Product benchmarking
13.3.17.4. Strategic initiatives
13.3.18. Lonza
13.3.18.1. Company overview
13.3.18.2. Financial performance
13.3.18.3. Product benchmarking
13.3.18.4. Strategic initiatives
13.3.19. Catalent Pharma Solutions
13.3.19.1. Company overview
13.3.19.2. Financial performance
13.3.19.3. Product benchmarking
13.3.19.4. Strategic initiatives
13.3.20. Jubilant Pharmova Limited
13.3.20.1. Company overview
13.3.20.2. Financial performance
13.3.20.3. Product benchmarking
13.3.20.4. Strategic initiatives
13.2. Company/Competition Categorization
13.2.1. Innovators
13.3. Vendor Landscape
13.3.1. List of key distributors and channel partners
13.3.2. Key customers
13.3.3. Key company market share analysis, 2022
13.3.4. F. Hoffmann-La Roche Ltd.
13.3.4.1. Company overview
13.3.4.2. Financial performance
13.3.4.3. Product benchmarking
13.3.4.4. Strategic initiatives
13.3.5. Novartis AG
13.3.5.1. Company overview
13.3.5.2. Financial performance
13.3.5.3. Product benchmarking
13.3.5.4. Strategic initiatives
13.3.6. GlaxoSmithKline plc
13.3.6.1. Company overview
13.3.6.2. Financial performance
13.3.6.3. Product benchmarking
13.3.6.4. Strategic initiatives
13.3.7. Pfizer, Inc.
13.3.7.1. Company overview
13.3.7.2. Financial performance
13.3.7.3. Product benchmarking
13.3.7.4. Strategic initiatives
13.3.8. Merck & Co., Inc.
13.3.8.1. Company overview
13.3.8.2. Financial performance
13.3.8.3. Product benchmarking
13.3.8.4. Strategic initiatives
13.3.9. AstraZeneca
13.3.9.1. Company overview
13.3.9.2. Financial performance
13.3.9.3. Product benchmarking
13.3.9.4. Strategic initiatives
13.3.10. Johnson & Johnson Services, Inc.
13.3.10.1. Company overview
13.3.10.2. Financial performance
13.3.10.3. Product benchmarking
13.3.10.4. Strategic initiatives
13.3.11. Sanofi SA
13.3.11.1. Company overview
13.3.11.2. Financial performance
13.3.11.3. Product benchmarking
13.3.11.4. Strategic initiatives
13.3.12. Eli Lilly and Company
13.3.12.1. Company overview
13.3.12.2. Financial performance
13.3.12.3. Product benchmarking
13.3.12.4. Strategic initiatives
13.3.13. AbbVie, Inc.
13.3.13.1. Company overview
13.3.13.2. Financial performance
13.3.13.3. Product benchmarking
13.3.13.4. Strategic initiatives
13.3.14. Thermo Fisher Scientific, Inc.
13.3.14.1. Company overview
13.3.14.2. Financial performance
13.3.14.3. Product benchmarking
13.3.14.4. Strategic initiatives
13.3.15. Wuxi Apptec
13.3.15.1. Company overview
13.3.15.2. Financial performance
13.3.15.3. Product benchmarking
13.3.15.4. Strategic initiatives
13.3.16. Samsung Biologics
13.3.16.1. Company overview
13.3.16.2. Financial performance
13.3.16.3. Product benchmarking
13.3.16.4. Strategic initiatives
13.3.17. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
13.3.17.1. Company overview
13.3.17.2. Financial performance
13.3.17.3. Product benchmarking
13.3.17.4. Strategic initiatives
13.3.18. Lonza
13.3.18.1. Company overview
13.3.18.2. Financial performance
13.3.18.3. Product benchmarking
13.3.18.4. Strategic initiatives
13.3.19. Catalent Pharma Solutions
13.3.19.1. Company overview
13.3.19.2. Financial performance
13.3.19.3. Product benchmarking
13.3.19.4. Strategic initiatives
13.3.20. Jubilant Pharmova Limited
13.3.20.1. Company overview
13.3.20.2. Financial performance
13.3.20.3. Product benchmarking
13.3.20.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 Global pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 3 Global pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 4 Global pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 5 Global pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 6 Global pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 7 Global pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 8 Global pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 9 Global pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 10 Global pharmaceutical manufacturing market, by region, 2018 - 2030 (USD Billion)
Table 11 North America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 12 North America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 13 North America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 14 North America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 15 North America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 16 North America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 17 North America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 18 North America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 19 U.S. pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 20 U.S. pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 21 U.S. pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 22 U.S. pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 23 U.S. pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 24 U.S. pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 25 U.S. pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 26 U.S. pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 27 Canada pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 28 Canada pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 29 Canada pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 30 Canada pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 31 Canada pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 32 Canada pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 33 Canada pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 34 Canada pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 35 Europe pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 36 Europe pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 37 Europe pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 38 Europe pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 39 Europe pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 40 Europe pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 41 Europe pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 42 Europe pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 43 Germany pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 44 Germany pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 45 Germany pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 46 Germany pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 47 Germany pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 48 Germany pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 49 Germany pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 50 Germany pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 51 UK pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 52 UK pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 53 UK pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 54 UK pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 55 UK pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 56 UK pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 57 UK pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 58 UK pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 59 France pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 60 France pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 61 France pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 62 France pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 63 France pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 64 France pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 65 France pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 66 France pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 67 Italy pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 68 Italy pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 69 Italy pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 70 Italy pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 71 Italy pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 72 Italy pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 73 Italy pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 74 Italy pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 75 Spain pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 76 Spain pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 77 Spain pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 78 Spain pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 79 Spain pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 80 Spain pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 81 Spain pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 82 Spain pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 83 Sweden pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 84 Sweden pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 85 Sweden pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 86 Sweden pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 87 Sweden pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 88 Sweden pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 89 Sweden pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 90 Sweden pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 91 Norway pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 92 Norway pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 93 Norway pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 94 Norway pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 95 Norway pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 96 Norway pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 97 Norway pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 98 Norway pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 99 Denmark pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 100 Denmark pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 101 Denmark pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 102 Denmark pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 103 Denmark pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 104 Denmark pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 105 Denmark pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 106 Denmark pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 107 Asia Pacific pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 108 Asia Pacific pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 109 Asia Pacific pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 110 Asia Pacific pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 111 Asia Pacific pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 112 Asia Pacific pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 113 Asia Pacific pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 114 Asia Pacific pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 115 China pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 116 China pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 117 China pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 118 China pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 119 China pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 120 China pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 121 China pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 122 China pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 123 Japan pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 124 Japan pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 125 Japan pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 126 Japan pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 127 Japan pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 128 Japan pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 129 Japan pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 130 Japan pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 131 India pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 132 India pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 133 India pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 134 India pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 135 India pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 136 India pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 137 India pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 138 India pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 139 Thailand pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 140 Thailand pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 141 Thailand pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 142 Thailand pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 143 Thailand pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 144 Thailand pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 145 Thailand pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 146 Thailand pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 147 South Korea pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 148 South Korea pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 149 South Korea pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 150 South Korea pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 151 South Korea pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 152 South Korea pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 153 South Korea pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 154 South Korea pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 155 Australia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 156 Australia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 157 Australia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 158 Australia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 159 Australia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 160 Australia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 161 Australia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 162 Australia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 163 Latin America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 164 Latin America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 165 Latin America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 166 Latin America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 167 Latin America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 168 Latin America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 169 Latin America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 170 Latin America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 171 Brazil pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 172 Brazil pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 173 Brazil pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 174 Brazil pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 175 Brazil pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 176 Brazil pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 177 Brazil pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 178 Brazil pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 179 Mexico pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 180 Mexico pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 181 Mexico pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 182 Mexico pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 183 Mexico pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 184 Mexico pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 185 Mexico pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 186 Mexico pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 187 Argentina pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 188 Argentina pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 189 Argentina pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 190 Argentina pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 191 Argentina pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 192 Argentina pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 193 Argentina pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 194 Argentina pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 195 Middle East and Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 196 Middle East and Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 197 Middle East and Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 198 Middle East and Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 199 Middle East and Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 200 Middle East and Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 201 Middle East and Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 202 Middle East and Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 203 South Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 204 South Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 205 South Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 206 South Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 207 South Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 208 South Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 209 South Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 210 South Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 211 Saudi Arabia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 212 Saudi Arabia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 213 Saudi Arabia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 214 Saudi Arabia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 215 Saudi Arabia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 216 Saudi Arabia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 217 Saudi Arabia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 218 Saudi Arabia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 219 UAE pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 220 UAE pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 221 UAE pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 222 UAE pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 223 UAE pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 224 UAE pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 225 UAE pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 226 UAE pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 227 Kuwait pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 228 Kuwait pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 229 Kuwait pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 230 Kuwait pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 231 Kuwait pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 232 Kuwait pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 233 Kuwait pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 234 Kuwait pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 2 Global pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 3 Global pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 4 Global pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 5 Global pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 6 Global pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 7 Global pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 8 Global pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 9 Global pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 10 Global pharmaceutical manufacturing market, by region, 2018 - 2030 (USD Billion)
Table 11 North America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 12 North America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 13 North America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 14 North America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 15 North America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 16 North America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 17 North America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 18 North America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 19 U.S. pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 20 U.S. pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 21 U.S. pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 22 U.S. pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 23 U.S. pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 24 U.S. pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 25 U.S. pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 26 U.S. pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 27 Canada pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 28 Canada pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 29 Canada pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 30 Canada pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 31 Canada pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 32 Canada pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 33 Canada pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 34 Canada pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 35 Europe pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 36 Europe pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 37 Europe pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 38 Europe pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 39 Europe pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 40 Europe pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 41 Europe pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 42 Europe pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 43 Germany pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 44 Germany pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 45 Germany pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 46 Germany pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 47 Germany pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 48 Germany pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 49 Germany pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 50 Germany pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 51 UK pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 52 UK pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 53 UK pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 54 UK pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 55 UK pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 56 UK pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 57 UK pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 58 UK pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 59 France pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 60 France pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 61 France pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 62 France pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 63 France pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 64 France pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 65 France pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 66 France pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 67 Italy pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 68 Italy pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 69 Italy pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 70 Italy pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 71 Italy pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 72 Italy pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 73 Italy pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 74 Italy pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 75 Spain pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 76 Spain pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 77 Spain pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 78 Spain pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 79 Spain pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 80 Spain pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 81 Spain pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 82 Spain pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 83 Sweden pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 84 Sweden pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 85 Sweden pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 86 Sweden pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 87 Sweden pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 88 Sweden pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 89 Sweden pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 90 Sweden pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 91 Norway pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 92 Norway pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 93 Norway pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 94 Norway pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 95 Norway pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 96 Norway pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 97 Norway pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 98 Norway pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 99 Denmark pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 100 Denmark pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 101 Denmark pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 102 Denmark pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 103 Denmark pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 104 Denmark pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 105 Denmark pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 106 Denmark pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 107 Asia Pacific pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 108 Asia Pacific pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 109 Asia Pacific pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 110 Asia Pacific pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 111 Asia Pacific pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 112 Asia Pacific pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 113 Asia Pacific pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 114 Asia Pacific pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 115 China pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 116 China pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 117 China pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 118 China pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 119 China pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 120 China pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 121 China pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 122 China pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 123 Japan pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 124 Japan pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 125 Japan pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 126 Japan pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 127 Japan pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 128 Japan pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 129 Japan pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 130 Japan pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 131 India pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 132 India pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 133 India pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 134 India pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 135 India pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 136 India pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 137 India pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 138 India pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 139 Thailand pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 140 Thailand pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 141 Thailand pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 142 Thailand pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 143 Thailand pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 144 Thailand pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 145 Thailand pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 146 Thailand pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 147 South Korea pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 148 South Korea pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 149 South Korea pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 150 South Korea pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 151 South Korea pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 152 South Korea pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 153 South Korea pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 154 South Korea pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 155 Australia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 156 Australia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 157 Australia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 158 Australia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 159 Australia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 160 Australia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 161 Australia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 162 Australia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 163 Latin America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 164 Latin America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 165 Latin America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 166 Latin America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 167 Latin America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 168 Latin America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 169 Latin America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 170 Latin America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 171 Brazil pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 172 Brazil pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 173 Brazil pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 174 Brazil pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 175 Brazil pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 176 Brazil pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 177 Brazil pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 178 Brazil pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 179 Mexico pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 180 Mexico pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 181 Mexico pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 182 Mexico pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 183 Mexico pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 184 Mexico pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 185 Mexico pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 186 Mexico pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 187 Argentina pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 188 Argentina pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 189 Argentina pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 190 Argentina pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 191 Argentina pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 192 Argentina pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 193 Argentina pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 194 Argentina pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 195 Middle East and Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 196 Middle East and Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 197 Middle East and Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 198 Middle East and Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 199 Middle East and Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 200 Middle East and Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 201 Middle East and Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 202 Middle East and Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 203 South Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 204 South Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 205 South Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 206 South Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 207 South Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 208 South Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 209 South Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 210 South Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 211 Saudi Arabia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 212 Saudi Arabia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 213 Saudi Arabia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 214 Saudi Arabia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 215 Saudi Arabia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 216 Saudi Arabia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 217 Saudi Arabia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 218 Saudi Arabia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 219 UAE pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 220 UAE pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 221 UAE pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 222 UAE pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 223 UAE pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 224 UAE pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 225 UAE pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 226 UAE pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 227 Kuwait pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 228 Kuwait pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 229 Kuwait pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 230 Kuwait pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 231 Kuwait pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 232 Kuwait pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 233 Kuwait pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 234 Kuwait pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Pharmaceutical manufacturing: market outlook
Fig. 9 Pharmaceutical manufacturing competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Pharmaceutical manufacturing market driver impact
Fig. 15 Pharmaceutical manufacturing market restraint impact
Fig. 16 Pharmaceutical manufacturing market strategic initiatives analysis
Fig. 17 Pharmaceutical manufacturing market: molecule type movement analysis
Fig. 18 Pharmaceutical manufacturing market: molecule type outlook and key takeaways
Fig. 19 Large molecules market estimates and forecast, 2018 - 2030
Fig. 20 Monoclonal Antibodies market estimates and forecast, 2018 - 2030
Fig. 21 Vaccines market estimates and forecast, 2018 - 2030
Fig. 22 Cell & Gene Therapy market estimates and forecast, 2018 - 2030
Fig. 23 Others market estimates and forecast, 2018 - 2030
Fig. 24 Small molecules market estimates and forecast, 2018 - 2030
Fig. 25 Pharmaceutical manufacturing market: drug development type movement analysis
Fig. 26 Pharmaceutical manufacturing market: drug development type outlook and key takeaways
Fig. 27 Outsource market estimates and forecast, 2018 - 2030
Fig. 28 In-house market estimates and forecast, 2018 - 2030
Fig. 29 Pharmaceutical manufacturing market: formulation movement analysis
Fig. 30 Pharmaceutical manufacturing market: formulation outlook and key takeaways
Fig. 31 Tablets market estimates and forecast, 2018 - 2030
Fig. 32 Capsules market estimates and forecast, 2018 - 2030
Fig. 33 Injectable market estimates and forecast, 2018 - 2030
Fig. 34 Sprays market estimates and forecast, 2018 - 2030
Fig. 35 Suspensions market estimates and forecast, 2018 - 2030
Fig. 36 Powders market estimates and forecast, 2018 - 2030
Fig. 37 Others market estimates and forecast, 2018 - 2030
Fig. 38 Pharmaceutical manufacturing market: route of administration movement analysis
Fig. 39 Pharmaceutical manufacturing market: route of administration outlook and key takeaways
Fig. 40 Oral market estimates and forecast, 2018 - 2030
Fig. 41 Topical market estimates and forecast, 2018 - 2030
Fig. 42 Parenteral market estimates and forecast, 2018 - 2030
Fig. 43 Inhalation market estimates and forecast, 2018 - 2030
Fig. 44 Others market estimates and forecast, 2018 - 2030
Fig. 45 Pharmaceutical manufacturing market: Therapy area movement analysis
Fig. 46 Pharmaceutical manufacturing market: Therapy Area outlook and key takeaways
Fig. 47 CVDs market estimates and forecast, 2018 - 2030
Fig. 48 Pain market estimates and forecast, 2018 - 2030
Fig. 49 Diabetes management market estimates and forecast, 2018 - 2030
Fig. 50 Cancer market estimates and forecast, 2018 - 2030
Fig. 51 Respiratory diseases market estimates and forecast, 2018 - 2030
Fig. 52 Others market estimates and forecast, 2018 - 2030
Fig. 53 Pharmaceutical manufacturing market: prescription movement analysis
Fig. 54 Pharmaceutical manufacturing market: prescription outlook and key takeaways
Fig. 55 Prescription medicines market estimates and forecast, 2018 - 2030
Fig. 56 Over-the-counter medicines market estimates and forecast, 2018 - 2030
Fig. 57 Pharmaceutical manufacturing market: age-group movement analysis
Fig. 58 Pharmaceutical manufacturing market: age-group outlook and key takeaways
Fig. 59 Children & Adolescents market estimates and forecast, 2018 - 2030
Fig. 60 Adults market estimates and forecast, 2018 - 2030
Fig. 61 Geriatric market estimates and forecast, 2018 - 2030
Fig. 62 Pharmaceutical manufacturing market: sales channel movement analysis
Fig. 63 Pharmaceutical manufacturing market: sales channel outlook and key takeaways
Fig. 64 Retail market estimates and forecast, 2018 - 2030
Fig. 65 Non-Retail market estimates and forecast, 2018 - 2030
Fig. 66 Global Pharmaceutical manufacturing market: regional movement analysis
Fig. 67 Global Pharmaceutical manufacturing market: regional outlook and key takeaways
Fig. 68 Global market share and leading players
Fig. 69 North America market share and leading players
Fig. 70 Europe market share and leading players
Fig. 71 Asia Pacific market share and leading players
Fig. 72 Latin America market share and leading players
Fig. 73 Middle East & Africa market share and leading players
Fig. 74 North America: SWOT
Fig. 75 Europe SWOT
Fig. 76 Asia Pacific SWOT
Fig. 77 Latin America SWOT
Fig. 78 MEA SWOT
Fig. 79 North America, by country
Fig. 80 North America
Fig. 81 North America market estimates and forecast, 2018 - 2030
Fig. 82 U.S. Key Country Dynamics
Fig. 83 U.S. market estimates and forecast, 2018 - 2030
Fig. 84 Canada Key Country Dynamics
Fig. 85 Canada market estimates and forecast, 2018 - 2030
Fig. 86 Europe
Fig. 87 Europe. market estimates and forecast, 2018 - 2030
Fig. 88 UK Key Country Dynamics
Fig. 89 UK market estimates and forecast, 2018 - 2030
Fig. 90 Germany Key Country Dynamics
Fig. 91 Germany market estimates and forecast, 2018 - 2030
Fig. 92 France Key Country Dynamics
Fig. 93 France market estimates and forecast, 2018 - 2030
Fig. 94 Italy Key Country Dynamics
Fig. 95 Italy market estimates and forecast, 2018 - 2030
Fig. 96 Spain Key Country Dynamics
Fig. 97 Spain market estimates and forecast, 2018 - 2030
Fig. 98 Sweden Key Country Dynamics
Fig. 99 Sweden market estimates and forecast, 2018 - 2030
Fig. 100 Norway Key Country Dynamics
Fig. 101 Norway market estimates and forecast, 2018 - 2030
Fig. 102 Denmark Key Country Dynamics
Fig. 103 Denmark market estimates and forecast, 2018 - 2030
Fig. 104 Asia Pacific Key Country Dynamics
Fig. 105 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 106 China Key Country Dynamics
Fig. 107 China market estimates and forecast, 2018 - 2030
Fig. 108 Japan Key Country Dynamics
Fig. 109 Japan market estimates and forecast, 2018 - 2030
Fig. 110 India Key Country Dynamics
Fig. 111 India market estimates and forecast, 2018 - 2030
Fig. 112 Australia Key Country Dynamics
Fig. 113 Australia market estimates and forecast, 2018 - 2030
Fig. 114 Thailand Key Country Dynamics
Fig. 115 Thailand market estimates and forecast, 2018 - 2030
Fig. 116 South Korea Key Country Dynamics
Fig. 117 South Korea market estimates and forecast, 2018 - 2030
Fig. 118 Latin America
Fig. 119 Latin America market estimates and forecast, 2018 - 2030
Fig. 120 Brazil Key Country Dynamics
Fig. 121 Brazil market estimates and forecast, 2018 - 2030
Fig. 122 Mexico Key Country Dynamics
Fig. 123 Mexico market estimates and forecast, 2018 - 2030
Fig. 124 Argentina Key Country Dynamics
Fig. 125 Argentina market estimates and forecast, 2018 - 2030
Fig. 126 Middle East and Africa
Fig. 127 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 128 Saudi Arabia Key Country Dynamics
Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 130 South Africa Key Country Dynamics
Fig. 131 South Africa market estimates and forecast, 2018 - 2030
Fig. 132 UAE Key Country Dynamics
Fig. 133 UAE market estimates and forecast, 2018 - 2030
Fig. 134 Kuwait Key Country Dynamics
Fig. 135 Kuwait market estimates and forecast, 2018 - 2030
Fig. 136 Participant categorization - Pharmaceutical manufacturing market
Fig. 137 Market share of key market players - Pharmaceutical manufacturing market
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Pharmaceutical manufacturing: market outlook
Fig. 9 Pharmaceutical manufacturing competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Pharmaceutical manufacturing market driver impact
Fig. 15 Pharmaceutical manufacturing market restraint impact
Fig. 16 Pharmaceutical manufacturing market strategic initiatives analysis
Fig. 17 Pharmaceutical manufacturing market: molecule type movement analysis
Fig. 18 Pharmaceutical manufacturing market: molecule type outlook and key takeaways
Fig. 19 Large molecules market estimates and forecast, 2018 - 2030
Fig. 20 Monoclonal Antibodies market estimates and forecast, 2018 - 2030
Fig. 21 Vaccines market estimates and forecast, 2018 - 2030
Fig. 22 Cell & Gene Therapy market estimates and forecast, 2018 - 2030
Fig. 23 Others market estimates and forecast, 2018 - 2030
Fig. 24 Small molecules market estimates and forecast, 2018 - 2030
Fig. 25 Pharmaceutical manufacturing market: drug development type movement analysis
Fig. 26 Pharmaceutical manufacturing market: drug development type outlook and key takeaways
Fig. 27 Outsource market estimates and forecast, 2018 - 2030
Fig. 28 In-house market estimates and forecast, 2018 - 2030
Fig. 29 Pharmaceutical manufacturing market: formulation movement analysis
Fig. 30 Pharmaceutical manufacturing market: formulation outlook and key takeaways
Fig. 31 Tablets market estimates and forecast, 2018 - 2030
Fig. 32 Capsules market estimates and forecast, 2018 - 2030
Fig. 33 Injectable market estimates and forecast, 2018 - 2030
Fig. 34 Sprays market estimates and forecast, 2018 - 2030
Fig. 35 Suspensions market estimates and forecast, 2018 - 2030
Fig. 36 Powders market estimates and forecast, 2018 - 2030
Fig. 37 Others market estimates and forecast, 2018 - 2030
Fig. 38 Pharmaceutical manufacturing market: route of administration movement analysis
Fig. 39 Pharmaceutical manufacturing market: route of administration outlook and key takeaways
Fig. 40 Oral market estimates and forecast, 2018 - 2030
Fig. 41 Topical market estimates and forecast, 2018 - 2030
Fig. 42 Parenteral market estimates and forecast, 2018 - 2030
Fig. 43 Inhalation market estimates and forecast, 2018 - 2030
Fig. 44 Others market estimates and forecast, 2018 - 2030
Fig. 45 Pharmaceutical manufacturing market: Therapy area movement analysis
Fig. 46 Pharmaceutical manufacturing market: Therapy Area outlook and key takeaways
Fig. 47 CVDs market estimates and forecast, 2018 - 2030
Fig. 48 Pain market estimates and forecast, 2018 - 2030
Fig. 49 Diabetes management market estimates and forecast, 2018 - 2030
Fig. 50 Cancer market estimates and forecast, 2018 - 2030
Fig. 51 Respiratory diseases market estimates and forecast, 2018 - 2030
Fig. 52 Others market estimates and forecast, 2018 - 2030
Fig. 53 Pharmaceutical manufacturing market: prescription movement analysis
Fig. 54 Pharmaceutical manufacturing market: prescription outlook and key takeaways
Fig. 55 Prescription medicines market estimates and forecast, 2018 - 2030
Fig. 56 Over-the-counter medicines market estimates and forecast, 2018 - 2030
Fig. 57 Pharmaceutical manufacturing market: age-group movement analysis
Fig. 58 Pharmaceutical manufacturing market: age-group outlook and key takeaways
Fig. 59 Children & Adolescents market estimates and forecast, 2018 - 2030
Fig. 60 Adults market estimates and forecast, 2018 - 2030
Fig. 61 Geriatric market estimates and forecast, 2018 - 2030
Fig. 62 Pharmaceutical manufacturing market: sales channel movement analysis
Fig. 63 Pharmaceutical manufacturing market: sales channel outlook and key takeaways
Fig. 64 Retail market estimates and forecast, 2018 - 2030
Fig. 65 Non-Retail market estimates and forecast, 2018 - 2030
Fig. 66 Global Pharmaceutical manufacturing market: regional movement analysis
Fig. 67 Global Pharmaceutical manufacturing market: regional outlook and key takeaways
Fig. 68 Global market share and leading players
Fig. 69 North America market share and leading players
Fig. 70 Europe market share and leading players
Fig. 71 Asia Pacific market share and leading players
Fig. 72 Latin America market share and leading players
Fig. 73 Middle East & Africa market share and leading players
Fig. 74 North America: SWOT
Fig. 75 Europe SWOT
Fig. 76 Asia Pacific SWOT
Fig. 77 Latin America SWOT
Fig. 78 MEA SWOT
Fig. 79 North America, by country
Fig. 80 North America
Fig. 81 North America market estimates and forecast, 2018 - 2030
Fig. 82 U.S. Key Country Dynamics
Fig. 83 U.S. market estimates and forecast, 2018 - 2030
Fig. 84 Canada Key Country Dynamics
Fig. 85 Canada market estimates and forecast, 2018 - 2030
Fig. 86 Europe
Fig. 87 Europe. market estimates and forecast, 2018 - 2030
Fig. 88 UK Key Country Dynamics
Fig. 89 UK market estimates and forecast, 2018 - 2030
Fig. 90 Germany Key Country Dynamics
Fig. 91 Germany market estimates and forecast, 2018 - 2030
Fig. 92 France Key Country Dynamics
Fig. 93 France market estimates and forecast, 2018 - 2030
Fig. 94 Italy Key Country Dynamics
Fig. 95 Italy market estimates and forecast, 2018 - 2030
Fig. 96 Spain Key Country Dynamics
Fig. 97 Spain market estimates and forecast, 2018 - 2030
Fig. 98 Sweden Key Country Dynamics
Fig. 99 Sweden market estimates and forecast, 2018 - 2030
Fig. 100 Norway Key Country Dynamics
Fig. 101 Norway market estimates and forecast, 2018 - 2030
Fig. 102 Denmark Key Country Dynamics
Fig. 103 Denmark market estimates and forecast, 2018 - 2030
Fig. 104 Asia Pacific Key Country Dynamics
Fig. 105 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 106 China Key Country Dynamics
Fig. 107 China market estimates and forecast, 2018 - 2030
Fig. 108 Japan Key Country Dynamics
Fig. 109 Japan market estimates and forecast, 2018 - 2030
Fig. 110 India Key Country Dynamics
Fig. 111 India market estimates and forecast, 2018 - 2030
Fig. 112 Australia Key Country Dynamics
Fig. 113 Australia market estimates and forecast, 2018 - 2030
Fig. 114 Thailand Key Country Dynamics
Fig. 115 Thailand market estimates and forecast, 2018 - 2030
Fig. 116 South Korea Key Country Dynamics
Fig. 117 South Korea market estimates and forecast, 2018 - 2030
Fig. 118 Latin America
Fig. 119 Latin America market estimates and forecast, 2018 - 2030
Fig. 120 Brazil Key Country Dynamics
Fig. 121 Brazil market estimates and forecast, 2018 - 2030
Fig. 122 Mexico Key Country Dynamics
Fig. 123 Mexico market estimates and forecast, 2018 - 2030
Fig. 124 Argentina Key Country Dynamics
Fig. 125 Argentina market estimates and forecast, 2018 - 2030
Fig. 126 Middle East and Africa
Fig. 127 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 128 Saudi Arabia Key Country Dynamics
Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 130 South Africa Key Country Dynamics
Fig. 131 South Africa market estimates and forecast, 2018 - 2030
Fig. 132 UAE Key Country Dynamics
Fig. 133 UAE market estimates and forecast, 2018 - 2030
Fig. 134 Kuwait Key Country Dynamics
Fig. 135 Kuwait market estimates and forecast, 2018 - 2030
Fig. 136 Participant categorization - Pharmaceutical manufacturing market
Fig. 137 Market share of key market players - Pharmaceutical manufacturing market
Companies Mentioned
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- GlaxoSmithKline plc
- Pfizer, Inc.
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson Services, Inc.
- Sanofi SA
- Eli Lilly and Company
- AbbVie, Inc.
- Thermo Fisher Scientific, Inc.
- Wuxi Apptec
- Samsung Biologics
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- Lonza
- Catalent Pharma Solutions
- Jubilant Pharmova Limited
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 170 |
| Published | July 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 516.48 billion |
| Forecasted Market Value ( USD | $ 929.9 billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
